Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Marks

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of the Royal Society of Medicine|February 28, 2025
Key SARS-CoV-2 testing strategies implemented in the UK: rationale and impactTom Fowler, Chris Kenny, Sarah Tunkel, et al.
Blood Advances|October 21, 2021
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematologyWilliam A Wood, Peter Marks, Robert M Plovnick, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disordersDiane Nugent, Suchitra S Acharya, Kimberly J Baumann, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2023
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think TankShanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, et al.
Mbio|February 14, 2023
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020Shuting Zhang, Peijun Ma, Marek Orzechowski, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing studyEleanor Fewings, Alexey Larionov, James Redman, et al.
Lancet (London, England)|September 17, 2021
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trialBernadette C Young, David W Eyre, Saroj Kendrick, et al.
Science (New York, N.Y.)|February 2, 2023
The NIH-led research response to COVID-19Francis Collins, Stacey Adam, Christine Colvis, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of the Royal Society of Medicine|February 28, 2025
Key SARS-CoV-2 testing strategies implemented in the UK: rationale and impactTom Fowler, Chris Kenny, Sarah Tunkel, et al.
Blood Advances|October 21, 2021
ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematologyWilliam A Wood, Peter Marks, Robert M Plovnick, et al.
British Journal of Haematology|January 20, 2007
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell diseaseElliott Vichinsky, Onyinye Onyekwere, John Porter, et al.
Expert Review of Hematology|March 15, 2023
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disordersDiane Nugent, Suchitra S Acharya, Kimberly J Baumann, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2023
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think TankShanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, et al.
Mbio|February 14, 2023
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020Shuting Zhang, Peijun Ma, Marek Orzechowski, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing studyEleanor Fewings, Alexey Larionov, James Redman, et al.
Lancet (London, England)|September 17, 2021
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trialBernadette C Young, David W Eyre, Saroj Kendrick, et al.
Science (New York, N.Y.)|February 2, 2023
The NIH-led research response to COVID-19Francis Collins, Stacey Adam, Christine Colvis, et al.
Pageof 7